Company / Financials
Bristol Myers Squibb Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$48.2B
FY2025 · -0.2% YoY
Net Income
$7.1B
FY2025 · +178.8% YoY
Profit Margin
14.6%
FY2025 · net income / revenue
ROE
38.2%
FY2025 · return on equity
Total Assets
$90.0B
FY2025
Total Debt
$44.8B
2.43x debt/equity
Equity
$18.5B
FY2025
ROA
7.8%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$48.2B-0.2% YoYNet Income HistoryProfit after all expenses and taxes$7.1B+178.8% YoYGross Profit HistoryRevenue minus cost of goods sold$30.7BCost of Revenue HistoryDirect costs of producing goods and services sold$13.9B-0.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$7.3B-13.6% YoYR&D Expense HistoryResearch and development spending$10.0B-10.8% YoYInterest Expense HistoryCost of borrowing and debt obligations$1.3BIncome Tax HistoryTotal income tax expense$2.3B+310.1% YoYEPS (Basic) HistoryBasic earnings per share$3.88+30.6% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles$3.86+30.8% YoY